Open Reading Frame 47: A Promising Drug Target Or Biomarker for Cancer Treatment

Target Name: Chromosome 16 open reading frame 47

NCBI ID: G388289

Chromosome 16 open reading frame 47

Other Name(s): Chromosome 16 open reading frame 47, transcript variant X1 | C16orf47 variant X1 | C16orf47 | Putative uncharacterized protein C16orf47 (isoform X1) | Putative uncharacterized protein C16orf47

Open Reading Frame 47: A Promising Drug Target Or Biomarker for Cancer Treatment

Chromosome 16 is one of the human chromosomes that are susceptible to genetic diseases because it contains a variety of genes, including some linked to cancer. Among them, open reading frame 47 (Chromosome 16 open reading frame 47, transcript variant X1) is a striking gene that plays a key role in cancer development.

open reading frame 47 is a gene that is on Chromosome 16. It is an open reading frame, which means its DNA sequence can be read and translated into protein. open reading frame 47 The protein encoded by the gene is a transmembrane protein that plays a variety of biological functions within cells.

In cancer, aberrant expression of open reading frame 47 is a common feature of many cancer types. It is closely related to the progression and treatment response of many cancers and is therefore considered a good target for cancer.

Currently, there are various studies exploring the potential of open reading frame 47 as a drug target or biomarker. Among them, some studies explored open reading frame 47 as a drug target for the treatment of cancer, while other studies explored the potential of open reading frame 47 as a tumor antigen.

Studies of open reading frame 47 as a drug target for cancer treatment have shown that inhibiting the expression of open reading frame 47 can significantly inhibit tumor growth and progression. These studies also showed that open reading frame 47 expression levels correlate with survival in cancer patients.

Studies of open reading frame 47 as a tumor antigen have shown that open reading frame 47 can be expressed in tumor cells and can stimulate immune responses as a tumor antigen. These studies also showed that open reading frame 47 expression levels correlate with tumor invasiveness and metastasis.

Therefore, open reading frame 47 is a promising drug target or biomarker that can be used to treat a variety of cancers. Future studies will continue to explore the biological functions of open reading frame 47 and its role in tumor treatment.

Protein Name: Chromosome 16 Open Reading Frame 47

The "Chromosome 16 open reading frame 47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Chromosome 16 open reading frame 47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets